Insider Buy ·Filed Jul 29, 2026
Insider cluster: 1 insiders, $88K total
Actionable Insight • Neutral
Monitor for additional insider buying or a material corporate catalyst (e.g., clinical data, partnership) before taking a position.
Final — all horizons settled through T+60d ⚠ clustered
NXTC ▼ -0.99% at T+60d
NEUTRAL call -0.99% · α vs SPY -3.46% · entry $5.03 → $4.98
T+1d
-17.59%
call -17.59% · α -18.30%
$4.15
settled 3mo ago
T+5d
+11.13%
call +11.13% · α +7.51%
$5.59
settled 3mo ago
T+20d
+19.98%
call +19.98% · α +16.01%
$6.04
settled 2mo ago
T+60d
-0.99%
call -0.99% · α -3.46%
$4.98
settled 4d ago
Price Chart
Loading chart...
Executive Summary
ADAR1 Capital Management, a 10% owner of NextCure, purchased $88K worth of NXTC shares across four open-market transactions over three days at ~$5/share. This represents approximately 0.44% of the company's $20M market cap, a modest but notable insider buy from a single large holder.
Key Financial Metrics
Direction
buying
Total Value
$88.0K
Insiders
1
Key Facts
- ADAR1 Capital Management, a 10% owner, purchased 17,608 shares of NXTC for a total of $88K between July 27-29, 2026.
- All purchases were open-market (code P) at an average price of ~$5.00 per share.
- The $88K buy represents ~0.44% of NXTC's $20M market cap, falling in the 'modest' proportionality band.
- This is a single-insider conviction buy, not a multi-insider cluster, which limits the signal strength per the literature.
Financial Impact
Insider purchase of $88K, or 0.44% of market cap, by a 10% owner.
insider ownership
Risk Factors
- Single-insider buys have weaker predictive power than multi-insider clusters.
- The $88K purchase is small in absolute terms and may reflect a routine position adjustment rather than a conviction signal.
- No recent corporate filings (earnings, pipeline updates) are provided to contextualize the insider's motivation.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (9 analysts)
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| INSIDER-BUY Data (Synthetic) | 0001940272-26-000012 |
17 reports for NXTC
75% Hit rate @ T+60 Went positive at some point 6 of 6 best @ T+60▲ +74.85%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | SC 13G | $5.44 | awaiting T+60 | — | $5.22 (−3.95%) |
Sep 25, 2026 4w ago | 425 | $5.08 | awaiting T+60 | — | $5.22 (+2.85%) |
Sep 25, 2026 4w ago | 8-K | $5.08 | awaiting T+60 | — | $5.22 (+2.85%) |
Aug 10, 2026 11w ago | 425 | $6.73 | awaiting T+60 | — | $5.22 (+22.36%) |
Aug 4, 2026 11w ago | 425 | $5.78 | awaiting T+60 | — | $5.22 (−9.60%) |
Aug 3, 2026 12w ago | Insider Buy | $5.78 | awaiting T+60 | — | $5.22 (−9.60%) |
Jul 29, 2026 12w ago | Insider Buy | $5.03 $4.98 | ▼ −0.99% | ▼ −3.46% | $5.22 (+3.88%) |
Jul 14, 2026 14w ago | 425 / 8-K | $6.58 $6.56 | ▼ −0.30% | ▼ −3.68% | $5.22 (−20.59%) |
Jul 14, 2026 14w ago | 8-K | $6.58 $6.56 | ▲ +0.30% | ▲ +3.68% | $5.22 (+20.59%) |
Jun 1, 2026 21w ago | 8-K | $3.38 $5.91 | ▲ +74.85% | ▲ +73.62% | $5.22 (+54.59%) |
Showing 10 of 17
US Market Status
Market Closed — Opens Tue (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers